Navigation Links
Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference
Date:5/18/2009

CPF Recognized for Advancing Research and Patient Advocacy Efforts

SAN DIEGO, May 18 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) today announced awards received at the American Thoracic Society's (ATS) International conference in San Diego, Calif. being held this week. The ATS meeting brings together the world's leading pulmonary, critical care and sleep physicians. The CPF received an award for a partner grant program with ATS that, to date, has funded $400,000 in new pulmonary fibrosis research funding. The organization also received a first-time award for its participation in the ATS Public Advisory Roundtable (PAR). The CPF is exhibiting in booth #2921 on "PAR Row" at the International meeting.

The CPF has partnered with the ATS since 2006 to provide peer-reviewed grants for innovative research in PF. To date, the CPF/ATS partner grant program has awarded grants to PF researchers at Johns Hopkins University (Baltimore, MD), Massachusetts General Hospital (Boston, Mass.), Ohio State University Medical Center (Columbus, Ohio) and Vanderbilt University Medical Center (Nashville, Tenn.).

"We are pleased to receive some very prestigious awards from ATS, and we're proud to continue this exciting partnership with ATS," said Mishka Michon, CEO of the CPF.

The CPF received the ATS Foundation's inaugural "Breathing for Life Award" for its participation in the ATS PAR, the patient voice of the ATS. The ATS PAR has created unparalleled synergy with ATS members by involving patients in providing support, shaping public policy and stimulating new research.

Due to the CPF's involvement with ATS and combined efforts to further educate doctors and researchers on PF, the disease is gaining more attention and PF is the subject of an increasing number of high profile sessions at the international conference. Sessions on PF at this year's meeting have included topics ranging from basic research areas in lung stem cells as well as clinical and translational research from bench to bedside.

The CPF also awarded an ATS travel grant, provided to fund a PF researcher's conference travel, to James P. Bridges, Ph.D. from Cincinnati Children's Hospital and Medical Center.

For a schedule of ATS events, please visit http://www.thoracic.org/sections/meetings-and-courses/international-conference/2009/index.html.

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring -- known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 19,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. United Concordia and Texas Oral Health Coalition Partner to Offer Free Dental Services
2. Coalition for Quality & Patient Safety of Chicagoland PSO Taps ECRI Institute PSO for Patient Safety Support
3. Concord Coalition Says New Trustees Report Demonstrates the Importance of Health Care Cost Control
4. PhRMA Statement on Healthcare Reform Coalition
5. Bipartisan Coalition Forms to Call for Chronic Disease to be Key Focus of Health Reform in Indiana and Nationally
6. Latino Coalition Highlights Importance of Personal Health Records At Economic Summit
7. Industry Coalition Advises Against Use of Dietary Supplements as Swine Flu Remedy, Cure
8. Coalition Says On-Site Infectious Medical Waste Treatment Key To Disease Control and Hospital Sustainability During a Pandemic
9. Obama Judicial Nominee Opposed By Coalition of Disability Rights Organizations
10. Coalition of Leaders in Science and Research Commend Obama Administration for Commitment to Medical Innovation During First 100 Days
11. Coalition to Protect Senior Care Applauds Inclusion of Long Term Care in Senate Finance Committee Roundtable Discussion on Health Care Delivery System Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of travel therapy ... MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason ... extensive financial and operational leadership experience to Advanced Inc. He began his career in ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of ... of an injury, patients must find the one that works for them. When an ... created a machine that worked and decided to share it with others. , He ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a class-leading provider of ... Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories keep track of ... new version is a faster and a more efficient product, allowing batch processing ...
(Date:12/2/2016)... ... 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, ... Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in 1934 ... details line up exactly with Bible Prophecy – a protected way for those who ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... & Author of Type 2 Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein ... Hour Power of Water, Global Climate Change and Your Health radio program syndicated ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... Awards Committee honored excellence in research, development and innovation ... The gala dinner was held in the presence of ... the Russian Federation , Natalia Sanina, ... Mikhail Murashko , Head of Roszdravnadzor, National Service ...
(Date:12/2/2016)... 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today ... Inc. ("PSI").  The combination of Texas -based ... -based PSI bring together both company,s clinical expertise and high-touch ... an industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... Dec. 2, 2016 Boston Scientific Corporation (NYSE: ... to acquire certain manufacturing assets and capabilities of the ... advanced biological tissue business, as well as a 15% ... million in cash. The Neovasc advanced biological tissue business ... Boston Scientific Lotus™ Valve System. * Upon completion ...
Breaking Medicine Technology: